REMEGEN CO. LTD YC 1 (REG) — Capital Reinvestment Ratio
REMEGEN CO. LTD YC 1 (REG) has a Capital Reinvestment Ratio of 3.82x as of December 2025, meaning it reinvests 4% of its operating cash flow (€52.34 Million) in capital expenditures (€200.01 Million). See how leveraged is REMEGEN CO. LTD YC 1's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
REMEGEN CO. LTD YC 1 Capital Reinvestment Ratio (2021–2025)
This chart tracks REMEGEN CO. LTD YC 1's Capital Reinvestment Ratio across 2 annual periods. Check how aggressively does REMEGEN CO. LTD YC 1 reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for REMEGEN CO. LTD YC 1 (2021–2025)
Year-by-year Capital Reinvestment Ratio for REMEGEN CO. LTD YC 1 from 2021 to 2025. For live market cap and broader valuation context, see REG stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.82x | €52.34 Million | €200.01 Million | ▲ +63.2% |
| 2021 | 2.34x | €263.63 Million | €617.34 Million | — |